SENSEI BIOTHERAPEUTICS INC (SNSE)
US81728A1088 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.13M | 13.01M | 17.80M | 7.20M | 16.60M | |||
| Marketable Securities | 27.87M | 52.75M | 89.30M | 140.50M | N/A | |||
| Other Current Assets | 1.10M | 1.49M | 1.40M | 900.00K | 3.50M | |||
| Total Current Assets | 48.10M | 67.25M | 108.60M | 148.50M | 20.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.07M | 7.04M | 9.70M | 4.60M | 1.30M | |||
| Other Non-Current Assets | 87.00K | 86.00K | 100.00K | 0.00 | 100.00K | |||
| Total Non-Current Assets | 5.16M | 7.12M | 9.80M | 4.70M | 1.30M | |||
| TOTAL ASSETS | 53.25M | 74.37M | 118.40M | 153.20M | 21.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 831.00K | 872.00K | 900.00K | 700.00K | 0.00 | |||
| Accrued Expenses | 2.93M | 3.08M | 3.70M | 1.80M | 900.00K | |||
| Accounts Payable | 1.68M | 1.69M | 4.50M | 2.50M | 3.90M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 5.44M | 5.64M | 9.10M | 4.90M | 4.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 206.00K | 768.00K | 1.60M | 1.70M | 600.00K | |||
| Other Non-Current Liabilities | 1.83M | 3.07M | 4.30M | 100.00K | 100.00K | |||
| Total Non-Current Liabilities | 2.03M | 3.84M | 5.90M | 1.80M | 700.00K | |||
| TOTAL LIABILITIES | 7.47M | 9.48M | 15.00M | 6.70M | 5.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -254.28M | -231.90M | -197.80M | -149.20M | -112.40M | |||
| Additional Paid In Capital | 300.04M | 297.00M | 302.20M | 296.00M | 56.00M | |||
| Common Shares | 3.00K | 3.00K | 0.00 | 0.00 | 72.30M | |||
| Other Shareholders' Equity | 14.00K | -209.00K | -1.00M | -300.00K | N/A | |||
| Shares Outstanding | 25.15M | 25.03M | 30.80M | 30.60M | 30.60M | |||
| Tangible Book Value per Share | 1.82 | 2.59 | 3.36 | 4.79 | -1.84 | |||
| Total Shareholders' Equity | 45.78M | 64.89M | 103.40M | 146.50M | 15.90M | |||
| TOTAL LIABILITIES AND EQUITY | 53.25M | 74.37M | 118.40M | 153.20M | 21.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.01 | 0.02 | 0.01 | 0.04 | |||
| Current Ratio | 8.84 | 11.92 | 11.93 | 30.31 | 4.19 | |||
| Return On Assets (ROA) | -55.96% | -45.85% | -41.04% | -24.01% | -94.39% | |||
| Return On Equity (ROE) | -65.10% | -52.55% | -46.99% | -25.11% | -127.04% | |||
All data in USD , ROIC based on taxRate of 0.21